Overview A Study of ZN-c5 in Participants With Breast Cancer Status: Recruiting Trial end date: 2022-04-01 Target enrollment: Participant gender: Summary This is a Phase 1 open-label, multicenter study to evaluate biomarkers for ZN-c5 in subjects with breast cancer Phase: Phase 1 Details Lead Sponsor: Zeno Alpha Inc.